Performance of fecal S100A12 as a novel non-invasive diagnostic biomarker for pediatric inflammatory bowel disease: a systematic review and meta-analysis
Open Access
- 22 April 2023
- journal article
- review article
- Published by Elsevier in Jornal de Pediatria
- Vol. 99 (5) , 432-442
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerBMC Medical Research Methodology, 2014
- Fecal S100A12 in Healthy Infants and ChildrenDisease Markers, 2013
- Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12Inflammatory Bowel Diseases, 2013
- S100A12: A noninvasive marker of inflammation in inflammatory bowel diseaseJournal of Digestive Diseases, 2013
- Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic ReviewDigestive Diseases and Sciences, 2012
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic ReviewGastroenterology, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Granulocyte Macrophage‐Colony‐stimulating Factor Autoantibodies and Increased Intestinal Permeability in Crohn DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2011
- Subclinical Intestinal Inflammation in Siblings of Children with Crohn’s DiseaseDigestive Diseases and Sciences, 2010
- The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJournal of Clinical Epidemiology, 2005